Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Ondas Inc
ONDS
$5.57B
| $69K | ﹤0.01% |
80,000
-220,324
| -73% | -$210K |
|
3552
Sentage Holdings
SNTG
$5.72M
| $69K | ﹤0.01% |
+27,200
| New | +$64.6K |
|
|
KA
3553
DELISTED
Kineta, Inc. Common Stock
KA
| $69K | ﹤0.01% |
26,916
-10,135
| -27% | -$34.2K |
|
3554
Precision Optics
POCI
$45.4M
| $68K | ﹤0.01% |
11,000
-1,367
| -11% | -$8.75K |
|
|
RGLS
3555
DELISTED
Regulus Therapeutics
RGLS
| $68K | ﹤0.01% |
46,100
+7,300
| +19% | +$9.72K |
|
|
SIFY
3556
Sify Technologies
SIFY
$1.14B
| $68K | ﹤0.01% |
6,017
-6,744
| -53% | -$55.4K |
|
3557
Stabilis Solutions
SLNG
$102M
| $68K | ﹤0.01% |
13,541
-7,459
| -36% | -$27.7K |
|
|
VSTA
3558
DELISTED
Vasta Platform
VSTA
| $68K | ﹤0.01% |
20,300
+1,400
| +7% | +$4.89K |
|
|
THRN
3559
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $67K | ﹤0.01% |
14,200
+1,100
| +8% | +$5.06K |
|
|
SANW
3560
DELISTED
S&W Seed Co
SANW
| $66K | ﹤0.01% |
2,864
-142
| -5% | -$3.38K |
|
|
ATHX
3561
DELISTED
Athersys, Inc. Common Stock
ATHX
| $66K | ﹤0.01% |
76,136
-12,900
| -14% | -$11.6K |
|
|
MOGU
3562
MOGU Inc
MOGU
$15.3M
| $65K | ﹤0.01% |
27,057
-4,500
| -14% | -$11.4K |
|
3563
NexGel
NXGL
$3.79M
| $65K | ﹤0.01% |
26,031
+5,600
| +27% | +$11K |
|
|
AMRN
3564
Amarin Corp
AMRN
$297M
| $64K | ﹤0.01% |
2,695
-1,140
| -30% | -$29.3K |
|
3565
Dolphin Entertainment
DLPN
$14.8M
| $64K | ﹤0.01% |
18,700
-800
| -4% | -$3.16K |
|
3566
Metalpha Technology Holding
MATH
$41.4M
| $64K | ﹤0.01% |
51,800
+3,487
| +7% | +$3.53K |
|
3567
Oriental Culture Holding
OCG
$3.22M
| $64K | ﹤0.01% |
32
-8
| -20% | -$14.3K |
|
3568
VerifyMe
VRME
$9.18M
| $64K | ﹤0.01% |
46,200
+15,892
| +52% | +$25.4K |
|
|
DWTX
3569
Dogwood Therapeutics
DWTX
$64.9M
| $64K | ﹤0.01% |
1,856
-80
| -4% | -$2.28K |
|
|
ORGS
3570
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $64K | ﹤0.01% |
4,590
-30
| -0.6% | -$356 |
|
|
CZOO
3571
DELISTED
Cazoo Group Ltd
CZOO
| $64K | ﹤0.01% |
541
+66
| +14% | +$11K |
|
3572
Castor Maritime
CTRM
$20.2M
| $63K | ﹤0.01% |
14,080
-330
| -2% | -$1.99K |
|
3573
Surrozen
SRZN
$284M
| $63K | ﹤0.01% |
7,580
+760
| +11% | +$7.14K |
|
|
EQRX
3574
DELISTED
EQRx, Inc. Common Stock
EQRX
| $63K | ﹤0.01% |
34,000
+11,100
| +48% | +$19.9K |
|
|
WHLR
3575
Wheeler Real Estate Investment Trust
WHLR
$390K
| – | – |
0
| – | – |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.